WuXi Biologics (Cayman) Inc. (Stock Code: 02269) Announces Increase in Issued Shares

Bulletin Express

Nov 19, 2025

WuXi Biologics (Cayman) Inc. (Stock Code: 02269) published a Next Day Disclosure Return dated 19 November 2025. The document indicates an increase in the company’s total issued share capital from 4,105,770,633 shares to 4,107,272,633 shares.

The change resulted from the issuance of 2,000 new ordinary shares at HKD4.67 per share, as well as the issuance of 1,500,000 new ordinary shares at HKD1.29 per share under the Pre-IPO Share Option Scheme adopted on 5 January 2016 (as amended). These issuances amount to a combined total of 1,502,000 new shares.

Following the completion of these transactions on 19 November 2025, the company’s total number of issued shares stands at 4,107,272,633. No repurchase, redemption, or cancellation of shares was disclosed in the announcement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1198061652"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1198061652\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1198061652?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-19 21:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1198061652","market":"us","top_or_hot":-1,"title":"WuXi Biologics (Cayman) Inc. (Stock Code: 02269) Announces Increase in Issued Shares","media":"Bulletin Express","content":"<p>WuXi Biologics (Cayman) Inc. (Stock Code: 02269) published a Next Day Disclosure Return dated 19 November 2025. The document indicates an increase in the company’s total issued share capital from 4,105,770,633 shares to 4,107,272,633 shares.</p>\n<p>The change resulted from the issuance of 2,000 new ordinary shares at HKD4.67 per share, as well as the issuance of 1,500,000 new ordinary shares at HKD1.29 per share under the Pre-IPO Share Option Scheme adopted on 5 January 2016 (as amended). These issuances amount to a combined total of 1,502,000 new shares.</p>\n<p>Following the completion of these transactions on 19 November 2025, the company’s total number of issued shares stands at 4,107,272,633. No repurchase, redemption, or cancellation of shares was disclosed in the announcement.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WuXi Biologics (Cayman) Inc. (Stock Code: 02269) Announces Increase in Issued Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWuXi Biologics (Cayman) Inc. (Stock Code: 02269) Announces Increase in Issued Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-19 21:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>WuXi Biologics (Cayman) Inc. (Stock Code: 02269) published a Next Day Disclosure Return dated 19 November 2025. The document indicates an increase in the company’s total issued share capital from 4,105,770,633 shares to 4,107,272,633 shares.</p>\n<p>The change resulted from the issuance of 2,000 new ordinary shares at HKD4.67 per share, as well as the issuance of 1,500,000 new ordinary shares at HKD1.29 per share under the Pre-IPO Share Option Scheme adopted on 5 January 2016 (as amended). These issuances amount to a combined total of 1,502,000 new shares.</p>\n<p>Following the completion of these transactions on 19 November 2025, the company’s total number of issued shares stands at 4,107,272,633. No repurchase, redemption, or cancellation of shares was disclosed in the announcement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02269","symbol_name":"药明生物","start_time":0,"source_url":"","article_id":"1198061652","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1198061652","pubTimestamp":1763557246,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"WuXi Biologics (Cayman) Inc. (Stock Code: 02269) published a Next Day Disclosure Return dated 19 November 2025. The document indicates an increase in the company’s total issued share capital from...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02269":"药明生物"},"translate_title":"WuXi Biologics(Cayman)Inc.（股份代号：02269）宣布增加已发行股份","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02269":1},"content_text":"WuXi Biologics (Cayman) Inc. (Stock Code: 02269) published a Next Day Disclosure Return dated 19 November 2025. The document indicates an increase in the company’s total issued share capital from 4,105,770,633 shares to 4,107,272,633 shares.\nThe change resulted from the issuance of 2,000 new ordinary shares at HKD4.67 per share, as well as the issuance of 1,500,000 new ordinary shares at HKD1.29 per share under the Pre-IPO Share Option Scheme adopted on 5 January 2016 (as amended). These issuances amount to a combined total of 1,502,000 new shares.\nFollowing the completion of these transactions on 19 November 2025, the company’s total number of issued shares stands at 4,107,272,633. No repurchase, redemption, or cancellation of shares was disclosed in the announcement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}